BMX as a Molecular Target for Radiosensitizing Agents

Summary

Provided are methods for modulating the proliferation of cells and tissues. In some embodiments, the methods include administering to a subject an effective amount of a modulator of a biological activity of a bone marrow X kinase (Bmx) gene product. Also provided are methods for increasing the radiosensitivity of a target cell or tissue, methods for suppressing tumor growth, methods for inhibiting tumor blood vessel growth, and compositions that include modulators of a biological activity of a bone marrow X kinase (Bmx) gene product.

Intellectual Property Status

U.S. Patent # 8,129,356 was issued March 6, 2012.

Inventors: 
Dennis HallahanChristopher Willey
Licensing manager: 
Taylor Jordan

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter